Multiplikator Forward P/S: STRATA Skin Sciences Inc. (SSKN)
STRATA Skin Sciences (SSKN) supplies laser systems for the treatment of vitiligo and psoriasis to clinics. The forward P/S ratio reflects market expectations, where 0.00 becomes the new value of the metric. Revenue is based on the sale of devices and consumables, which stabilizes cash flow. However, the limited capital of physicians restricts the growth of procedure fees, weakening the issuer's pricing power.
Ringkesan rincian data analitis strataskinsciences.com (SSKN)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal STRATA Skin Sciences|SSKN - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal STRATA Skin Sciences, Inc.|SSKN - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku STRATA Skin Sciences, Inc.|SSKN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan STRATA Skin Sciences|Rasio cepet strataskinsciences.com
- rincian asil keuangan lan kelipatan valuasi:
SSKN - Penghasilan resik perusahaan|Bathi sing dikarepake STRATA Skin Sciences|SSKN - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi STRATA Skin Sciences, Inc.|SSKN - Pangali PEG|Pangali EV/EBITDA STRATA Skin Sciences, Inc.|SSKN - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan STRATA Skin Sciences|SSKN - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan strataskinsciences.com|SSKN - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep STRATA Skin Sciences
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:SSKN (STRATA Skin)
Moderate cyclicality in demand for STRATA Skin Sciences (SSKN) laser systems and stable revenue from consumables make the capitalization-to-forecasted-revenue ratio a key tool for assessing business resilience. The trend in the expected price-to-sales ratio allows investors to determine the asset's current margin of safety and promptly identify either the emergence of an investment discount or a systemic deterioration of the company's fundamental indicators.
Karo sapa STRATA Skin Sciences saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|ibs.inc (INBS) - Rasio rega marang prakiraan pendapatan|XAIR - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan PFSA|GCTK (glucotrack.com) - Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|VERO (Venus Concept Corporation) - Rega forward marang dodolan|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|Multiplikator Forward P/S aethlonmedical.com AEMD|ASXC: Multiplikator forward rega marang pendapatan|Avinger Inc. - Rasio rega marang pendapatan sing dikarepake|BSGM: Multiplikator Forward P/S|Cutera Inc (CUTR) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan KNW|NARI: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Nevro (NVRO)|Rasio kapitalisasi marang dodolan sing dikarepake reshapelifesciences.com|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
